Irum N. Khan

Intensive Care Medicine

333 Cedar St
New Haven, CT 6510.

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 09, 2026

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

Journal: Blood advances

Published: October 27, 2025

Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.

Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.

Journal: Haematologica

Published: August 31, 2025

Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials.

Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials.

Journal: Blood

Published: July 18, 2025

Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.

Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.

Journal: Blood cancer journal

Published: June 18, 2025

Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.

Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.

Journal: British journal of haematology

Published: February 13, 2025

Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment.

Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment.

Journal: The Journal of clinical investigation

Published: November 22, 2024

FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.

FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.

Journal: NPJ precision oncology

Published: November 12, 2024

Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.

Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.

Journal: Blood advances

Published: April 05, 2024

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Journal: Cell death discovery

Published: January 22, 2024

Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Journal: Leukemia

Published: December 12, 2023

Regulation of HOX gene expression in AML.

Regulation of HOX gene expression in AML.

Journal: Blood cancer journal

Published: November 27, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026